Aromatase excess in cancers of breast, endometrium and ovary
- 24 May 2007
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 106 (1-5) , 81-96
- https://doi.org/10.1016/j.jsbmb.2007.05.027
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Phase II trial of anastrozole in women with asymptomatic müllerian cancerGynecologic Oncology, 2003
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Regulation of Steroidogenic Acute Regulatory Protein Expression and Progesterone Production in Endometriotic Stromal CellsJournal of Clinical Endocrinology & Metabolism, 2001
- The Two Tumor Necrosis Factor Receptors Mediate Opposite Effects on Differentiation and Glucose Metabolism in Human Adipocytes in Primary CultureEndocrinology, 2000
- Regulated CYP19 Aromatase Transcription in Breast Stromal FibroblastsJournal of Clinical Endocrinology & Metabolism, 2000
- Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft modelEuropean Journal Of Cancer, 1994
- Determination of aromatase cytochrome P450 messenger ribonucleic acid in human breast tissue by competitive polymerase chain reaction amplificationJournal of Clinical Endocrinology & Metabolism, 1992
- Inhibitory effect of a new androstenedione derivative, 14α-hydroxy-4-androstene-3,6,17-trione (14α-OHAT) on aromatase activity of human uterine tumorsThe Journal of Steroid Biochemistry and Molecular Biology, 1990